Navigation Links
Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment
Date:8/17/2008

s media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We cannot guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors and Other Uncertainties" section of our Form 20-F lodged with the U.S. Securities and Exchange Commission."

CONTACT:

Alan Robertson

Chief Executive Officer

Tel: +61-2-9454-7200

Email: alan.robertson@pharmaxis.com.au

RELEASED THROUGH:

Australia:

Virginia Nicholls

Tel: +61-417-610-824

Email: virginia.nicholls@pharmaxis.com.au

United States:

Brandon Lewis, Trout Group

Tel: +1-646-378-2915

Email: blewis@troutgroup.com


'/>"/>
SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bronchitol Cystic Fibrosis Dose Trial Results Positive
2. Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial
3. Pharmaxis Establishes Named Patient Program for Bronchitol
4. Pharmaxis Long-Term Safety Study of Bronchitol Completes
5. Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
6. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
7. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
8. Neurobiological Technologies Reaches Patient Enrollment Target For Interim Analysis of Viprinex(TM) Phase 3 Stroke Trials
9. Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma
10. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
11. Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015  As cannabis prohibition ends one state at a time, more cannabis entrepreneurs are coming up with brilliant ... and the primary reason is lack of funding. ... ... ... ...
(Date:5/5/2015)... 5, 2015  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... months ended March 31, 2015 and reaffirmed its revenue, ... 2015. First Quarter 2015 Highlights Include: ... of 72% as compared to $10.9 million for the ... non-GAAP EBITDA of $11.5 million, an increase of 170% as ...
(Date:5/5/2015)... , May 5, 2015  Abaxis, Inc. (NasdaqGS: ABAX ... announced today that Clint Severson , chairman and chief ... Lynch 2015 Health Care Conference on Tuesday, May 12, 2015 ... the Encore at the Wynn in Las Vegas, ... worldwide developer, manufacturer and marketer of portable blood analysis systems ...
Breaking Medicine Technology:Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9
... CSL Behring today announced that the U.S. Food and ... License Application (BLA) for a human 4-factor prothrombin complex concentrate ... warfarin) in patients with acute major bleeding. If approved by ... first agent of its kind available in the United States. ...
... 29, 2012 Specialty Silicone Fabricators (SSF), a ... device community, inaugurated its state-of-the-art 102,000 square-foot facility ... efficiency, the facility joins all Paso Robles departments, ... facilities in Tustin, Calif. and Elk Rapids, Mich. ...
Cached Medicine Technology:CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy 2CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy 3Specialty Silicone Fabricators Inaugurates New State-of-the-Art Facility in Paso Robles 2
(Date:5/5/2015)... DC (PRWEB) May 05, 2015 ... Hope Initiative, a new study aimed at determining how ... patients. RG is an international non-profit providing rare disease ... sequencing technology, connections to scientists and researchers, and help ... crowdfunding. , “I am excited to see how crowdfunding ...
(Date:5/5/2015)... On April 8th, 2015, at the famous Avalon ... Durkin Entertainment’s “RockNRolla” EcoLuxe Lounge, a daylong event organized ... placement in TV and film. , A gathering ... sound and socially conscious products and services, the EcoLuxe ... appearances at various awards ceremonies and festivals each year, ...
(Date:5/5/2015)... RF Technologies®, a leading provider of personal ... Management Solution with Voice Alarms. The ST750 will play ... to wait for assistance when it detects them starting ... 16 different melodies or tones or silent alerting, by ... Code Alert®. , For 28 years, Sensatec Fall ...
(Date:5/5/2015)... 2015 In the upbeat Moms Helping Moms ... moms to support each other. Parenting is a tough ... makes it so much easier. Mothers talk about how ... less alone and help them realize there’s no perfect parent; ... who are clearly dear friends share that it's just that, ...
(Date:5/5/2015)... AR (PRWEB) May 05, 2015 ... is collaborating with American Eagle Outfitters on a ... enhance natural beauty. , For the debut ... with Aerie by American Eagle ; the ... brand's body-image campaign, called "Aerie REAL," uses models ...
Breaking Medicine News(10 mins):Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:Choices Recovery Mishawaka Talks About Overcoming Adversity with Actor Matthew Ziff at the “RockNRolla Movie Awards” EcoLuxe Lounge 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3
... say that breast-feeding can negate the risks of breast cancer ... the age of 25. ,The findings of ... April 16 at the 2007 annual meeting of the American ... ,"Breastfeeding may have a protective effect that negates the ...
... increasingly viewing cured meats with caution. One reason is the ... According to a recent study, the nitrites ... fixative) could well be setting the lungs on a journey ... , The research led by Dr. Rui ...
... to Irish researchers, a smoking ban which began March 2004, ... drastic cut //in air pollution, the health of bar workers ... researchers gave an 83 percent reduction in air pollution and ... the report, which was published in the American Journal of ...
... simply no effect on arthritis, yet another study says. It ... analysis of 20 studies. // ,"We do not have ... on patients' pain," says author Peter Jüni, head of clinical ... ,The paper comes a little more than a ...
... in multiple sclerosis (MS) has been found to also reduce ... one of the most common and debilitating symptoms of MS. ... of Neurology?, the scientific journal of the American Academy of ... the AFFIRM and SENTINEL studies, which involved 2,138 men and ...
... beyond standard monitoring and testing schedules// ,Infection ... Hopkins Hospital have ordered testing for the two ... to its pediatric intensive care unit. ... methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) ...
Cached Medicine News:Health News:Breastfeeding Keeps Breast Cancer At Bay- For Older Mothers 2Health News:Hotdogs And Co.-The Long And Short Of It 2Health News:Ireland’s Smoke Ban Seems To Do The Tric 2Health News:Chondroitin may Not Have Any Beneficial Effect on Arthritis, New Study Says 2Health News:Chondroitin may Not Have Any Beneficial Effect on Arthritis, New Study Says 3Health News:MS Drug Helps Reduce Vision Loss 2Health News:Johns Hopkins Begins Aggressive Screening for 'superbugs' in Children 2Health News:Johns Hopkins Begins Aggressive Screening for 'superbugs' in Children 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: